星坦股份有限公司
Update：2026/11/10
Industries
Main Industry
Health Care
Main Product/Service
SymptomSquirrel establishes a brand-new medical connection model between doctors and patients. Your patients and research participants will use the SymptomSquirrel app to answer pre-configured questionnaires and record their medical status, allowing the system to analyze changes in patient condition on a daily, weekly, and monthly basis. You can view results in real-time, manage prescription medications, and receive alert notifications when conditions change, allowing you to manage your patients' physical health with peace of mind.
The content above was translated by Ai
Founded Year
2018
Unified Business No.
50850770
Status
Closed
Number of Employees
0
Total Paid-in
Capital
200,000 (NT$)
Location of Company
Taiwan
, New Taipei City
Company names, registration status, legal representatives, founding years, paid-in capital, registered addresses, and other details are sourced from business registration records maintained by Taiwan’s Administration of Commerce, Ministry of Economic Affairs. Exit status includes Emerging Stock Board listings, M&A, and IPOs. Information on overseas expansion is self-reported by startups.
Note 1: FINDIT compiles company information from public and other sources for reference and does not serve as a point of contact for the companies listed.
Note 2: Some company profiles and product/service descriptions are translated using AI and provided for reference only. In case of discrepancies or ambiguity, the original text prevails.
Exclusive content for members
Members-only content. Please log in to access.
About the Company
Founded in Taiwan in 2022, SymtomTrace is dedicated to the research and development of telemedicine software, tracking patient conditions to ensure uninterrupted care. Through collaboration with clinicians and researchers, integrating technological resources, and utilizing AI and big data database analysis, it establishes a brand-new medical care model.
The content above was translated by Ai
